INFUSYSTEM HOLDINGS, INC Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation
INFUSYSTEM HOLDINGS, INC (INFU) had Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation of $288.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation · last filed 2023-03-16
- 2022-09-30: Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation $288.00K.
- 2022-06-30: Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation $288.00K.
- 2021-12-31: Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation $288.00K.
- 2021-09-30: Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation $288.00K.
| Period end | Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation |
|---|---|
| 2022-09-30 | $288.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $288.00K 10-Q · filed 2022-08-04 |
| 2021-12-31 | $288.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $288.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $288.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |